|
Name |
p-Mentha-1,3,8-triene
|
Molecular Formula | C10H14 | |
IUPAC Name* |
1-methyl-4-prop-1-en-2-ylcyclohexa-1,3-diene
|
|
SMILES |
CC1=CC=C(CC1)C(=C)C
|
|
InChI |
InChI=1S/C10H14/c1-8(2)10-6-4-9(3)5-7-10/h4,6H,1,5,7H2,2-3H3
|
|
InChIKey |
XNMPFDIYAMOYRM-UHFFFAOYSA-N
|
|
Synonyms |
p-Mentha-1,3,8-triene; 1,3,8-p-Menthatriene; p-Menthatriene; 18368-95-1; 1-methyl-4-prop-1-en-2-ylcyclohexa-1,3-diene; p-1,3,8-Menthatriene; p-Menta-1,3,8-triene; 1,3,8-para-Menthatriene; 1,3,8-menthatriene; 1,3-Cyclohexadiene, 1-methyl-4-(1-methylethenyl)-; ZDY5H4QWH3; 1-methyl-4-(prop-1-en-2-yl)cyclohexa-1,3-diene; 1-Isopropenyl-4-methyl-1,3-cyclohexadiene; P-MENTHATRIENE,P-MENTHA-1,3,8-TRIENE; 2-Methyl-5-(1-methylethenyl)-1,3-Cyclohexadiene; UNII-ZDY5H4QWH3; CHEBI:89242; DTXSID60171462; ZINC59585784; 1-Isopropenyl-4-methyl-1,3-cyclohexadiene #; 1-Methyl-4-(1-methylethenyl)-1,3-cyclohexadiene; Q27161428; 1-Methyl-4-(1-methylethenyl)-1,3-cyclohexadiene, 9CI
|
|
CAS | 18368-95-1 | |
PubChem CID | 176983 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 134.22 | ALogp: | 3.0 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.508 |
Caco-2 Permeability: | -4.434 | MDCK Permeability: | 0.00001280 |
Pgp-inhibitor: | 0.009 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.001 |
Blood-Brain-Barrier Penetration (BBB): | 0.366 | Plasma Protein Binding (PPB): | 84.72% |
Volume Distribution (VD): | 2.517 | Fu: | 23.74% |
CYP1A2-inhibitor: | 0.783 | CYP1A2-substrate: | 0.909 |
CYP2C19-inhibitor: | 0.356 | CYP2C19-substrate: | 0.893 |
CYP2C9-inhibitor: | 0.356 | CYP2C9-substrate: | 0.352 |
CYP2D6-inhibitor: | 0.345 | CYP2D6-substrate: | 0.824 |
CYP3A4-inhibitor: | 0.01 | CYP3A4-substrate: | 0.376 |
Clearance (CL): | 1.271 | Half-life (T1/2): | 0.713 |
hERG Blockers: | 0.031 | Human Hepatotoxicity (H-HT): | 0.633 |
Drug-inuced Liver Injury (DILI): | 0.029 | AMES Toxicity: | 0.022 |
Rat Oral Acute Toxicity: | 0.061 | Maximum Recommended Daily Dose: | 0.238 |
Skin Sensitization: | 0.949 | Carcinogencity: | 0.694 |
Eye Corrosion: | 0.933 | Eye Irritation: | 0.983 |
Respiratory Toxicity: | 0.578 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000198 | 0.459 | D0O1UZ | 0.200 | ||||
ENC002218 | 0.388 | D03KEK | 0.156 | ||||
ENC002403 | 0.350 | D0N0OU | 0.152 | ||||
ENC000395 | 0.350 | D0WO8W | 0.149 | ||||
ENC002138 | 0.333 | D06XWB | 0.149 | ||||
ENC001066 | 0.317 | D0Z8SF | 0.149 | ||||
ENC000555 | 0.317 | D0X0WU | 0.147 | ||||
ENC002219 | 0.286 | D0H6VY | 0.145 | ||||
ENC000194 | 0.273 | D04GJN | 0.145 | ||||
ENC001484 | 0.259 | D01PJR | 0.143 |